To determine the blood stability of the nanoformulation in vivo, different samples including DOX, ACC@DOX-CaSi, and ACC@DOX-CaSi-PAMAM-FA/mPEG were intravenously injected into mice (n = 3) with no tumor burden, and the equivalent DOX concentration was maintained at 5 mg/kg. Blood (20 μl) was extracted from each mouse at given time points, and the red blood cells were removed via low-speed centrifugation. The DOX fluorescence intensity in the blood samples was then measured on a fluorescence spectrometer.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.